** Shares of the clinical research and development services
provider VIML.NS fall as much as 19.8%, their biggest intraday
percentage fall since March 14, 2012
** Co on Saturday reported a slump in qtrly profit, hurt by
a fall in revenue from operations https://bit.ly/2NBwVv1
** Co also said it will acquire 100% of equity shares of
Emtac Laboratories Private
** About 100,400 shares change hands in morning trade,
compared with 30-day average of 19,463
** At last close, stock down 61% this year
(Reporting by Nallur Sethuraman in Bengaluru)
((Sethuraman.NR@thomsonreuters.com; (+91 8067496031); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))